Inflammatory bowel disease (IBD) is a multifactorial disease, which is thought to be an interplay between genetic, environment, microbiota, and immune-mediated factors. Dysbiosis in the gut microbial composition, caused by antibiotics and diet, is closely related to the initiation and progression of IBD. Differences in gut microbiota composition between IBD patients and healthy individuals have been found, with reduced biodiversity of commensal microbes and colonization of opportunistic microbes in IBD patients. Gut microbiota can, therefore, potentially be used for diagnosing and prognosticating IBD, and predicting its treatment response. Currently, there are no curative therapies for IBD. Microbiota-based interventions, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, have been recognized as promising therapeutic strategies. Clinical studies and studies done in animal models have provided sufficient evidence that microbiota-based interventions may improve inflammation, the remission rate, and microscopic aspects of IBD. Further studies are required to better understand the mechanisms of action of such interventions. This will help in enhancing their effectiveness and developing personalized therapies. The present review summarizes the relationship between gut microbiota and IBD immunopathogenesis. It also discusses the use of gut microbiota as a noninvasive biomarker and potential therapeutic option.
Citations
Citations to this article as recorded by
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement Great Iruoghene Edo, Alice Njolke Mafe, Ali B.M. Ali, Patrick Othuke Akpoghelie, Emad Yousif, Jesse Innocent Apameio, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Yasal Garba, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Umar, Dilber Uzun Oz International Journal of Biological Macromolecules.2025; 289: 138633. CrossRef
Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release Great Iruoghene Edo, Alice Njolke Mafe, Nawar. F. Razooqi, Ebuka Chukwuma Umelo, Tayser Sumer Gaaz, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Patrick Othuke Akpoghelie, Rapheal Ajiri Opiti, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Uma Designed Monomers and Polymers.2025; 28(1): 1. CrossRef
Helminths in alternative therapeutics of inflammatory bowel disease Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal Intestinal Research.2025; 23(1): 8. CrossRef
Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats Min Cui, Wei-Ming Yang, Ping Yao Scientific Reports.2025;[Epub] CrossRef
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights Linda Galasso, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Federica Vitale, Alberto Nicoletti, Mattia Paratore, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco Cancers.2025; 17(3): 368. CrossRef
Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid Zhuoya Wang, Tian Liu, Li Liu, Jian Xie, Furui Tang, Yimin Pi, Yuchun Zhong, Zhidong He, Wenming Zhang, Cihua Zheng Pharmacological Research.2025; 213: 107663. CrossRef
Therapeutic systems based on natural gut microbiota modulators: the latest advances in the treatment of inflammatory bowel disease Zelin Guan, Peilin Niu, Qichao Tan, Yidong Wang, Shujing Deng, Danyang Wang, Kai Dong, Jianfeng Xing, Cuiyu You Materials Advances.2025; 6(5): 1578. CrossRef
Metabolic musculoskeletal disorders in patients with inflammatory bowel disease Young Joo Yang, Seong Ran Jeon The Korean Journal of Internal Medicine.2025; 40(2): 181. CrossRef
Photobiomodulation and the oral-gut microbiome axis: therapeutic potential and challenges Neda Hakimiha, Somayeh Jahani Sherafat, E-Liisa Laakso, Reza Fekrazad Frontiers in Medicine.2025;[Epub] CrossRef
Dinamiche del microbioma: dai cambiamenti nel corso della vita alla disbiosi nelle patologie tumorali Marcella NUNZIATO Biochimica Clinica.2025;[Epub] CrossRef
Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer Xilun Cui, Changfeng Li, Jing Zhong, Yuanda Liu, Pengtuo Xiao, Chang Liu, Mengwei Zhao, Wei Yang Frontiers in Immunology.2025;[Epub] CrossRef
Metabolic Disorders and Inflammatory Bowel Diseases Hye Kyung Hyun, Jae Hee Cheon Gut and Liver.2025; 19(3): 307. CrossRef
Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis Ji Eun Baek, Jung-Bin Park, June Hwa Bae, Min Hyun Kim, Seung Wook Hong, Sung Wook Hwang, Jong Lyul Lee, Yong Sik Yoon, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Suk-Kyun Yang, Sang Hyoung Park Gut and Liver.2025; 19(3): 388. CrossRef
Personalized Microbiome Modulation to Improve Clinical Outcomes in Pediatric Inflammatory Bowel Disease: A Multi-Omics and Interventional Approach Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca, Ileana Enătescu, Laura Olariu, Oana Belei Microorganisms.2025; 13(5): 1047. CrossRef
Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment Timoth Mkilima Annals of the New York Academy of Sciences.2025; 1548(1): 29. CrossRef
Gastric Cancer and Microbiota: Exploring the Microbiome’s Role in Carcinogenesis and Treatment Strategies Daniela-Cornelia Lazăr, Sorin-Dan Chiriac, George-Andrei Drăghici, Elena-Alina Moacă, Alexandra Corina Faur, Mihaela-Flavia Avram, Vladiana-Romina Turi, Mihaela-Roxana Nicolin, Adrian Goldiș, Matin Asad Salehi, Radu Jipa Life.2025; 15(7): 999. CrossRef
TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon Annals of Medicine.2025;[Epub] CrossRef
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics Himani Pandey, Prabudh Goel, Varunvenkat M Srinivasan, Daryl W T Tang, Sunny H Wong, Devi Lal World Journal of Hepatology.2025;[Epub] CrossRef
MH002, a Novel Butyrate-Producing Consortium of Six Commensal Bacterial Strains Has Immune-Modulatory and Mucosal-Healing Properties Iris Pinheiro, Selin Bolca, Lien Van den Bossche, Wiebe Vanhove, Sara Van Ryckeghem, Davide Gottardi, Debby Laukens, Sam Possemiers International Journal of Molecular Sciences.2025; 26(13): 6167. CrossRef
The Role of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Livestock and Poultry Gut Health: A Review Taojing Yue, Yanan Lu, Wenli Ding, Bowen Xu, Cai Zhang, Lei Li, Fuchun Jian, Shucheng Huang Metabolites.2025; 15(7): 478. CrossRef
Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies Siyuan Bu, Xiaozhen Cheng, Meng Chen, Yongduo Yu Pharmacogenomics and Personalized Medicine.2025; Volume 18: 219. CrossRef
A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran Samira Saedi, Safoura Derakhshan, Javid Sadeghi, Alka Hasani, Manouchehr Khoshbaten, Vahdat Poortahmasebi, Somayeh Ahmadi Letters in Applied Microbiology.2025;[Epub] CrossRef
Modulatory effects of synbiotic blend on selected human fecal bacteria and TNFα + LPS-induced inflammation in human intestinal epithelial cells Anita Rawat, Arka Bhattacharya, Rupa Tharu, Ruchika Maurya, Sanjay Kumar Bhadada, Mahendra Bishnoi, Kanthi Kiran Kondepudi The Microbe.2025; 8: 100512. CrossRef
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies Jiyoung Yoon, Daein Kim, You Sun Kim Intestinal Research.2025; 23(4): 430. CrossRef
Annexin A1 levels affect microbiota in health and DSS-induced colitis/inflammatory bowel disease development Luana Filippi Xavier, Ranko Gacesa, Gustavo Henrique Oliveira da Rocha, Milena Fronza Broering, Pablo Scharf, Fabiana da Silva Lima, Klaas Nico Faber, Hermie Harmsen, Christian Hoffmann, Sandra Helena Poliselli Farsky Frontiers in Immunology.2025;[Epub] CrossRef
The Effect of Cucumaria frondosa Tentacles Hydrolysates on Dextran Sulfate Sodium-Induced Colitis: Integrated Metagenomics and Metabolomics Analysis Senyu Zhang, Qiuting Wang, Shunmin Gong, Mingbo Li, Yu Zhang, Leilei Sun, Liqin Sun Foods.2025; 14(20): 3483. CrossRef
Therapeutic Potential and Functional Mechanisms of Probiotics as Prospective anti-inflammatory Agents Ridhika Bangotra, Bisma Habib, Mohd. Younis, Gurleen Kour, Nisha Kapoor, Ritu Mahajan, Zabeer Ahmed, Bijender Kumar Bajaj Probiotics and Antimicrobial Proteins.2025;[Epub] CrossRef
The gut immune axis in ulcerative colitis: insights from microbiome research Rufaida Wasim Molecular Biology Reports.2025;[Epub] CrossRef
Integrating gut microbiota and metabolomics in pediatric inflammatory bowel disease: insights into pathogenesis and potential role of precision medicine Rui Dong, Xiaoling Meng, Haiyan Hu, Jie Pan, Wei Wang European Journal of Medical Research.2025;[Epub] CrossRef
Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases Yanyu Cui, Zhendong Feng, Qihan Zhao, Haoran Dai, Yang Zheng, Hongliang Rui, Baoli Liu Frontiers in Immunology.2025;[Epub] CrossRef
Natural polyphenols in ulcerative colitis: preclinical mechanisms of action and therapeutic potential Chengu Niu, Jing Zhang, Patrick I. Okolo International Journal of Food Sciences and Nutrition.2025; 76(8): 825. CrossRef
Effects of stoma discharge reinfusion on low anterior resection syndrome and the gut microbiota following sphincter-preserving surgery for middle and low rectal cancer: a randomized clinical trial Shiwei Zhang, Liang He, Luyao Zhang, Jianan Sun, Yanjun Wang, Meiling Wang, Yinquan Zhao, Xuan Sun, Yang Gong, Zhong Li, Yuchen Guo, Quan Wang Updates in Surgery.2025;[Epub] CrossRef
A Comprehensive Narrative Review of Potential Gastrointestinal Adverse Effects From Micro(nano) Plastic Exposure Priyata Dutta, Sana Rabeeah, Alejandra Vargas, Edward C. Oldfield, David A. Johnson Clinical Gastroenterology and Hepatology.2025;[Epub] CrossRef
The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease Xingyu Shen, Yue Li, Deqiang Wang, Kang Sun Frontiers in Immunology.2025;[Epub] CrossRef
Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation Yuyuan Hu, Yuhang Yang, Yan Li, Qiang Zhang, Wei Zhang, Jinghan Jia, Zhuoyi Han, Jinxi Wang Frontiers in Immunology.2025;[Epub] CrossRef
Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer Devi Lal, Himani Pandey Onco.2025; 5(4): 50. CrossRef
Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy Miljana Glazar, Sonia Facchin Academia Nutrition and Dietetics.2025;[Epub] CrossRef
Oxidized Wheat Germ Protein Induces Oxidative Stress and Inflammation by Altering Gut Microbiota in Mice Yiming Li, Wenliang Zhao, Kun Zhan, Luanfeng Wang, Fang Wang, Haizhao Song, Fei Zeng, Zebin Weng, Xinchun Shen ACS Food Science & Technology.2025;[Epub] CrossRef
Editorial: Environments-pathogens-the gut microbiota and host diseases Jinbo Xiong, Zunji Shi Frontiers in Microbiology.2024;[Epub] CrossRef
Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, Rosa Vaccaro, Ludovica Garro, Simone Carotti, Ludovica Ceci, Paolo Onori, Luigi Pannarale, Antonio Franchitto, Eugenio Gaudio, Arianna Casini Neurogastroenterology & Motility.2024;[Epub] CrossRef
Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, Sankha Bhattacharya, Bhupendra G. Prajapati ACS Pharmacology & Translational Science.2024; 7(4): 967. CrossRef
Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review Luana Alexandrescu, Alina Doina Nicoara, Doina Ecaterina Tofolean, Alexandra Herlo, Andreea Nelson Twakor, Cristina Tocia, Anamaria Trandafir, Andrei Dumitru, Eugen Dumitru, Cristian Florentin Aftenie, Ionela Preotesoiu, Elena Dina, Ioan Tiberiu Tofolean International Journal of Molecular Sciences.2024; 25(15): 8451. CrossRef
Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis Sara Deleu, Inge Jacobs, Jorge F. Vazquez Castellanos, Sare Verstockt, Bruna Trindade de Carvalho, Ana Subotić, Bram Verstockt, Kaline Arnauts, Lowie Deprez, Eva Vissers, Matthias Lenfant, Greet Vandermeulen, Gert De Hertogh, Kristin Verbeke, Gianluca Mat Nutrients.2024; 16(16): 2668. CrossRef
The emerging role of the gut microbiota and its application in inflammatory bowel disease Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Anquan Shang, Francis Atim Akanyibah, Fei Mao Biomedicine & Pharmacotherapy.2024; 179: 117302. CrossRef
Bifidogenic Effect of Human Milk Oligosaccharides on Pediatric IBD Fecal Microbiota Nize Otaru, Danica Bajic, Pieter Van den Abbeele, Saskia Vande Velde, Stephanie Van Biervliet, Robert E. Steinert, Ateequr Rehman Microorganisms.2024; 12(10): 1977. CrossRef
Analysis of the Preventive Effect of Lonicera caerulea Pomace and Its Isolated Components on Colitis in Mice Based on Gut Microbiota and Serum Metabolomics Zinuo Zhou, Xinwen Huang, Baixi Zhang Antioxidants.2024; 13(12): 1478. CrossRef
Gut microbiota mediated T cells regulation and autoimmune diseases Nabeel Khalid Bhutta, Xiujin Xu, Cuiqin Jian, Yifan Wang, Yi Liu, Jinlyu Sun, Bingnan Han, Shandong Wu, Ansar Javeed Frontiers in Microbiology.2024;[Epub] CrossRef
Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects Yibing Hu, Zhenping Wu, Xiaoyun Yang, Jin Ding, Qunying Wang, Hao Fang, Lujian Zhu, Minli Hu BMC Microbiology.2024;[Epub] CrossRef